Stanford University School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2024

  1. Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

    Nature Medicine, Vol. 30, Núm. 8, pp. 2199-2207

  2. Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma

    Blood Advances, Vol. 8, Núm. 17, pp. 4581-4592